LeMaitre Vascular Other Non-Current Liabilities 2010-2024 | LMAT
LeMaitre Vascular Annual Other Non-Current Liabilities (Millions of US $) |
|
---|---|
2023 | $2 |
2022 | $2 |
2021 | $3 |
2020 | $5 |
2019 | $4 |
2018 | $3 |
2017 | $1 |
2016 | $2 |
2015 | $1 |
2014 | $0 |
2013 | $0 |
2012 | $0 |
2011 | $0 |
2010 | $0 |
2009 | $0 |
LeMaitre Vascular Quarterly Other Non-Current Liabilities (Millions of US $) |
|
---|---|
2024-09-30 | $1 |
2024-06-30 | $2 |
2024-03-31 | $2 |
2023-12-31 | $2 |
2023-09-30 | $2 |
2023-06-30 | $2 |
2023-03-31 | $2 |
2022-12-31 | $2 |
2022-09-30 | $2 |
2022-06-30 | $3 |
2022-03-31 | $3 |
2021-12-31 | $3 |
2021-09-30 | $4 |
2021-06-30 | $5 |
2021-03-31 | $5 |
2020-12-31 | $5 |
2020-09-30 | $5 |
2020-06-30 | $5 |
2020-03-31 | $4 |
2019-12-31 | $4 |
2019-09-30 | $3 |
2019-06-30 | $2 |
2019-03-31 | $2 |
2018-12-31 | $3 |
2018-09-30 | $2 |
2018-06-30 | $1 |
2018-03-31 | $1 |
2017-12-31 | $1 |
2017-09-30 | $1 |
2017-06-30 | $2 |
2017-03-31 | $2 |
2016-12-31 | $2 |
2016-09-30 | $1 |
2016-06-30 | $1 |
2016-03-31 | $1 |
2015-12-31 | $1 |
2015-09-30 | $1 |
2015-06-30 | $1 |
2015-03-31 | $0 |
2014-12-31 | $0 |
2014-09-30 | $0 |
2014-06-30 | $0 |
2014-03-31 | $0 |
2013-12-31 | $0 |
2013-09-30 | $0 |
2013-06-30 | $0 |
2013-03-31 | $0 |
2012-12-31 | $0 |
2012-09-30 | $0 |
2012-06-30 | $0 |
2012-03-31 | $0 |
2011-12-31 | $0 |
2011-09-30 | $0 |
2011-06-30 | $0 |
2011-03-31 | $0 |
2010-12-31 | $0 |
2010-09-30 | $0 |
2010-06-30 | $0 |
2010-03-31 | $0 |
2009-12-31 | $0 |
2009-09-30 | $0 |
2009-06-30 | $0 |
2009-03-31 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $2.247B | $0.193B |
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $221.767B | 27.38 |
Boston Scientific (BSX) | United States | $151.377B | 43.52 |
Stryker (SYK) | United States | $149.082B | 32.08 |
EssilorLuxottica (ESLOY) | France | $125.055B | 0.00 |
Medtronic (MDT) | Ireland | $117.214B | 17.41 |
Lonza Group Ag (LZAGY) | Switzerland | $45.950B | 0.00 |
Haleon (HLN) | United Kingdom | $43.139B | 28.03 |
GE HealthCare Technologies (GEHC) | United States | $40.136B | 20.82 |
ResMed (RMD) | United States | $37.119B | 30.50 |
Terumo (TRUMY) | Japan | $28.886B | 41.07 |
Koninklijke Philips (PHG) | Netherlands | $25.642B | 19.63 |
Zimmer Biomet Holdings (ZBH) | United States | $22.107B | 14.07 |
Insulet (PODD) | United States | $19.438B | 77.40 |
Baxter (BAX) | United States | $16.737B | 10.89 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.065B | 0.00 |
BellRing Brands (BRBR) | United States | $10.084B | 40.57 |
Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.966B | 33.87 |
Demant (WILYY) | Denmark | $8.735B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.433B | 14.95 |
ICU Medical (ICUI) | United States | $4.121B | 39.23 |
Prestige Consumer Healthcare (PBH) | United States | $3.893B | 19.36 |
Envista Holdings (NVST) | United States | $3.678B | 27.40 |
Haemonetics (HAE) | United States | $3.430B | 16.74 |
Perrigo (PRGO) | Ireland | $3.366B | 9.91 |
GN Store Nord (GNNDY) | Denmark | $3.027B | 19.41 |
Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.927B | 18.84 |
Neogen (NEOG) | United States | $2.495B | 28.75 |
AtriCure (ATRC) | United States | $2.067B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.464B | 25.63 |
InMode (INMD) | Israel | $1.462B | 8.79 |
AdaptHealth (AHCO) | United States | $1.430B | 10.22 |
BioLife Solutions (BLFS) | United States | $1.313B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.270B | 0.00 |
Owens & Minor (OMI) | United States | $1.150B | 8.99 |
Evolus (EOLS) | United States | $0.922B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.887B | 15.64 |
CeriBell (CBLL) | United States | $0.833B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.830B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.649B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.561B | 24.73 |
Surmodics (SRDX) | United States | $0.511B | 0.00 |
Omeros (OMER) | United States | $0.502B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.432B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.429B | 0.00 |
Valneva SE (VALN) | France | $0.412B | 0.00 |
ZimVie (ZIMV) | United States | $0.401B | 33.77 |
Quanterix (QTRX) | United States | $0.370B | 0.00 |
Cerus (CERS) | United States | $0.360B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.322B | 30.67 |
Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
Biote (BTMD) | United States | $0.309B | 6.76 |
OraSure Technologies (OSUR) | United States | $0.291B | 19.50 |
Canopy Growth (CGC) | Canada | $0.265B | 0.00 |
Zynex (ZYXI) | United States | $0.263B | 55.13 |
High Tide (HITI) | Canada | $0.239B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.233B | 3.28 |
Utah Medical Products (UTMD) | United States | $0.208B | 15.52 |
Aurora Cannabis (ACB) | Canada | $0.203B | 0.00 |
Brainsway (BWAY) | Israel | $0.197B | 104.70 |
MacroGenics (MGNX) | United States | $0.190B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.154B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.149B | 0.00 |
FitLife Brands (FTLF) | United States | $0.145B | 18.27 |
Quipt Home Medical (QIPT) | United States | $0.135B | 0.00 |
Jin Medical (ZJYL) | China | $0.125B | 0.00 |
Fonar (FONR) | United States | $0.102B | 11.54 |
Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
InterCure (INCR) | Israel | $0.077B | 0.00 |
Exagen (XGN) | United States | $0.072B | 0.00 |
INLIF (INLF) | $0.071B | 0.00 | |
Rockwell Medical (RMTI) | United States | $0.066B | 34.00 |
Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
Apyx Medical (APYX) | United States | $0.055B | 0.00 |
Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
Modular Medical (MODD) | United States | $0.051B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.051B | 0.00 |
United-Guardian (UG) | United States | $0.050B | 14.35 |
ImmuCell (ICCC) | United States | $0.048B | 0.00 |
Safety Shot (SHOT) | United States | $0.031B | 0.00 |
Nephros (NEPH) | United States | $0.018B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
Flora Growth (FLGC) | United States | $0.011B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.005B | 0.00 | |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.001B | 0.00 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |